Advertisement

AAPS PharmSciTech

, Volume 5, Issue 3, pp 82–89 | Cite as

Transdermal delivery of zidovudine (AZT): The effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin

  • Nuntakan Suwanpidokkul
  • Phensri Thongnopnua
  • Kaisri Umprayn
Article

Abstract

The purpose of this study was to investigate the effects of vehicles, enhancers, and polymer membranes on 3-azido-3-deoxythymidine (AZT) permeation across cadaver pig skin. Four binary vehicles (ethanol/water, isopropyl alcohol/water, polyethylene glycol 400/water, and ethanol/isopropyl myristate [IPM] were tested for AZT solubility and permeability across pig skin; ethanol/IPM (50/50, vol/vol) demonstrated the highest AZT flux (185.23 μ/cm2/h). Next, the addition of various concentrations of different enhancers (N-methyl-2-pyrrolidone [NMP], oleic acid, and lauric acid) to different volume ratios of ethanol/IPM was investigated for their effect on AZT solubility and permeability across pig skin. The use of 2 conbinations (ethanol/IPM [20/80] plus 10% NMP and ethanol/IPM [30/70] plus 10% NMP) resulted in increased AZT solubility (42.6 and 56.27 mg/mL, respectively) and also high AZT flux values (284.92 and 460.34 μg/cm2/h, respectively) without appreciable changes in lag times (6.25 and 7.49 hours, respectively) when compared with formulations using only ethanol/IPM at 20/80 and 30/70 volume ratios without addition of the enhancer NMP. Finally, AZT permeation across pig skin covered with a microporous polyethylene (PE) membrane was investigated. The addition of the PE membrane to the pig skin reduced AZT flux values to ∼50% of that seen with pig skin alone. However, the AZT flux value attained with ethanol/IPM (30/70) plus 10% NMP was 215.30 μg/cm2/h, which was greater than the target flux (208 μg/cm2/h) needed to maintain the steady-state plasma concentration in humans. The results obtained from this study will be helpful in the development of an AZT transdermal drug delivery system.

Keywords

Zidovudine permeation enhancer binary vehicles polymer membrane transdermal delivery system 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chien YW, Wearley LL. Aids and chemotherapy.Drugs of Today. 1989;25:19–25.Google Scholar
  2. 2.
    Merigan TC, Skowron G. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.Am J Med. 1990;88(suppl 5B):S11-S15.CrossRefGoogle Scholar
  3. 3.
    Kieburtz KD, Siedlin M, Lambert JS, et al. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.J Acquir Immune Defic Syndr. 1992;5:60–64.Google Scholar
  4. 4.
    Seki T, Kawaguchi T, Sugibayashi K, Juni K, Morimoto Y. Percutaneous absorption of azidothymidine in rats.Int J Pharm. 1989;57:73–75.CrossRefGoogle Scholar
  5. 5.
    Seki T, Toeda C, Kawaguchi T, Juni K, Sugubayashi K, Morimoto Y. Enhanced transdermal delivery of zidovudine in rats and human skin.Chem Pharm Bull (Tokyo). 1990;38:3086–3089.Google Scholar
  6. 6.
    Seki T, Kawaguchi T, Juni K. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs.Pharm Res. 1990;7:948–952.CrossRefGoogle Scholar
  7. 7.
    Kararli TT, Kirchhoff CF, Penzotti SC Jr. Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene-like enhancers: In vivo-in vitro correlations.J Control Release. 1995;34:43–51.CrossRefGoogle Scholar
  8. 8.
    Kim DD, Chien YW. Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation.J Pharm Sci. 1996;85:214–219.CrossRefGoogle Scholar
  9. 9.
    Jin Y, Seki T, Juni K. Transdermal absorption of zidovudine from ethanol-isopropyl myristate mixed system and influence of probenecid on it in rats.Drug Dev Ind Pharm. 1996;22:1217–1221.CrossRefGoogle Scholar
  10. 10.
    Jin Y, Seki T, Morimoto Y, Juni K. Effect of application volume of ethanol-isopropyl myristate mixed solvent system on permeation of zidovudine and probenecid through rat skin.Drug Dev Ind Pharm. 2000;26:193–198.CrossRefGoogle Scholar
  11. 11.
    Thomas NS, Panchagnula R. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action.Eur J Pharm Sci. 2003;18:71–79.CrossRefGoogle Scholar
  12. 12.
    Bond JR, Barry BW. Damaging effect of acetone on the permeability barrier of hairless mouse skin compared with that of human skin.Int J Pharm. 1988;41:91–93.CrossRefGoogle Scholar
  13. 13.
    Bond JR, Barry BW. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.J Invest Dermatol. 1988;90:810–813.CrossRefGoogle Scholar
  14. 14.
    Catz P, Friend DR. Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin.Int J Pharm. 1990;58:93–102.CrossRefGoogle Scholar
  15. 15.
    Sato K, Sugibayashi K, Morimoto Y. Species differences in percutaneous absorption of nicorandil.J Pharm Sci. 1991;80:104–107.CrossRefGoogle Scholar
  16. 16.
    Fang JY, Wu PC, Huang YB, Tsai YH. In vitro permeation study of capsaicin and its synthetic derivatives from ointment bases using various skin types.Int J Pharm. 1995;126:119–128.CrossRefGoogle Scholar
  17. 17.
    Wu PC, Huang YB, Fang JY, Tsai YH. In vitro percutaneous absorption of captopril.Int J Pharm. 1997;148:41–46.CrossRefGoogle Scholar
  18. 18.
    Rastogi SK, Singh J. Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: permeability and Fourier transform infrared spectroscopy studies.AAPS PharmSciTech. 2003;4(3):E29:1–9.CrossRefGoogle Scholar
  19. 19.
    Kenneth CJ, ed. Solution and solubioity.Solubility and Related Properties. New York, NY: Marcel Dekker, 1986:37–49.Google Scholar
  20. 20.
    Higuchi T, Connors KA. Phase solubility techniques.Adv Anal Chem Instrum. 1965;4:117–212.Google Scholar
  21. 21.
    Harrison SM, Barry BW, Dugard PH. Effects of freezing on human skin permeability.J Pharm Pharmacol. 1984;36:261–262.Google Scholar
  22. 22.
    Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability.J Pharm Pharmacol. 1992;44:640–645.Google Scholar
  23. 23.
    Lieb LM, Nash RA, Matias JR, Orentreich N. A new in vitro method for transepidermal water loss: A possible method for moisturizer evaluation.J Soc Cosmet Chem. 1988;39:107–119.Google Scholar
  24. 24.
    Klecker RW, Collins JM, Yarchoan R, et al. Plasma and cerebrospinal fluid pharmacokinetics of 3-azido-3-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.Clin Pharmacol Ther. 1987;41:407–412.CrossRefGoogle Scholar
  25. 25.
    Goldberg-Cettina M, Liu P, Nightingale J, Kurihara-Bergstrom T. Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols.Int J Pharm. 1995;114:237–245.CrossRefGoogle Scholar
  26. 26.
    Shinha VR, Maninder PK. Permeation enhancers for transdermal drug delivery.Drug Dev Ind Pharm. 2000;26:1131–1140.CrossRefGoogle Scholar
  27. 27.
    Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery.Eur J Pharm Sci. 2001;14:101–114.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2004

Authors and Affiliations

  • Nuntakan Suwanpidokkul
    • 1
  • Phensri Thongnopnua
    • 2
  • Kaisri Umprayn
    • 3
  1. 1.The Government Pharmaceutical OrganizationBangkokThailand
  2. 2.Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical SciencesChulalongkorn UniversityBangkokThailand
  3. 3.Department of Manufacturing Pharmacy, Faculty of Pharmaceutical SciencesChulalongkorn UniversityBangkokThailand

Personalised recommendations